Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| 908 Devices Inc.MASS · Entity 5564 | Director | June 10, 2026 | June 12, 2026 |
| DA32 Life Science Tech Acquisition Corp.DALS · Entity 110669 | Director | July 27, 2021 | July 27, 2021 |
| Quanterix CorpQTRX · Entity 6649 | Director · Executive Chairman | July 05, 2022 | July 06, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
908 Devices Inc.
Report date June 10, 2026 · Filed June 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 165,390 |
Reported balance
After 2026-06-10 transaction · row 1
1 source rowRow 1 · 2026-06-10 · Exercise / conversion · Acquired 14,083 · Balance 165,390 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-06-10 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-10 · Exercise / conversion · Disposed 14,083 · Balance 0 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F3: The RSUs became fully vested on June 10, 2026, the day prior to the 2026 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 13,656 |
Reported balance
After 2026-06-11 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-06-11 · Grant · Acquired 13,656 · Balance 13,656 F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F4: The RSUs become fully vested on June 11, 2027 or the day prior to the 2027 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. |
| Stock Option (option to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $8.22 · Expires 2036-06-10 | Direct | 6,209 |
Reported balance
After 2026-06-11 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-06-11 · Grant · Acquired 6,209 · Balance 6,209 F5: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following June 11, 2026, subject to the reporting person's continued service through the applicable vesting date. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 329,675 |
Reported balance
Holding disclosure · report date 2026-06-10 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 329,675 F2: The securities are owned directly by the E. Kevin Hrusovsky 2012 Irrevocable Trust. The reporting person's spouse and children are trustees of E. Kevin Hrusovsky 2012 Irrevocable Trust and have joint voting and dispositive control with respect to all securities held by E. Kevin Hrusovsky 2012 Irrevocable Trust and the reporting person may be deemed to be the beneficial owner of the securities held by E. Kevin Hrusovsky 2012 Irrevocable Trust. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested.
F2: The securities are owned directly by the E. Kevin Hrusovsky 2012 Irrevocable Trust. The reporting person's spouse and children are trustees of E. Kevin Hrusovsky 2012 Irrevocable Trust and have joint voting and dispositive control with respect to all securities held by E. Kevin Hrusovsky 2012 Irrevocable Trust and the reporting person may be deemed to be the beneficial owner of the securities held by E. Kevin Hrusovsky 2012 Irrevocable Trust.
F3: The RSUs became fully vested on June 10, 2026, the day prior to the 2026 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date.
F4: The RSUs become fully vested on June 11, 2027 or the day prior to the 2027 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date.
F5: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following June 11, 2026, subject to the reporting person's continued service through the applicable vesting date.
DA32 Life Science Tech Acquisition Corp.
Report date July 27, 2021 · Filed July 27, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class B Common StockSEC Table II · derivative / convertible security | Direct | Not disclosed |
Reported balance
Holding disclosure · report date 2021-07-27 · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · Balance Not disclosed F1: The reporting person owns 30,000 shares of Class B Common Stock which are convertible into shares of Class A Common Stock as described under the heading "Description of Securities" in the Issuer's registration statement on Form S-1 (File No. 333-257679) and have no expiration date. |
Filing footnotes · ownership attribution and instrument terms
F1: The reporting person owns 30,000 shares of Class B Common Stock which are convertible into shares of Class A Common Stock as described under the heading "Description of Securities" in the Issuer's registration statement on Form S-1 (File No. 333-257679) and have no expiration date.
Quanterix Corp
Report date July 05, 2022 · Filed July 06, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 910,249 |
Reported balance
After 2022-07-05 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-07-05 · Sale · Disposed 960 · Balance 910,249 F1: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 2,068 RSUs. F2: This transaction was executed in multiple trades at prices ranging from $16.18 to $17.10. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3: Includes 58,604 restricted stock units and 39,815 shares of common stock subject to performance based vesting. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 2,068 RSUs.
F2: This transaction was executed in multiple trades at prices ranging from $16.18 to $17.10. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: Includes 58,604 restricted stock units and 39,815 shares of common stock subject to performance based vesting.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 11, 2026 Filed Jun 12, 2026 16:49 UTC | 908 Devices Inc. MASS · Entity 5564 | GrantStock Option (option to buy) · Derivative | 6,209 | $0.00 Strike: $8.22 | $0.00 |
DisclosureSEC source: 0001252546-26-000003 · form4-06122026_080654.xml · derivative · entry 5 HRUSOVSKY E KEVIN · CIK 0001252546 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,209 Underlying: Common Stock · 6,209 shares Expires 2036-06-10 F5 · derivative.exercise_date: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following June 11, 2026, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| June 11, 2026 Filed Jun 12, 2026 16:49 UTC | 908 Devices Inc. MASS · Entity 5564 | GrantRestricted Stock Units · Derivative | 13,656 | $0.00 | $0.00 |
DisclosureSEC source: 0001252546-26-000003 · form4-06122026_080654.xml · derivative · entry 4 HRUSOVSKY E KEVIN · CIK 0001252546 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,656 Underlying: Common Stock · 13,656 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F4 · derivative.exercise_date: The RSUs become fully vested on June 11, 2027 or the day prior to the 2027 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. F4 · derivative.expiration_date: The RSUs become fully vested on June 11, 2027 or the day prior to the 2027 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 16:49 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionRestricted Stock Units · Derivative | 14,083 | $0.00 | $0.00 |
DisclosureSEC source: 0001252546-26-000003 · form4-06122026_080654.xml · derivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,083 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F3 · derivative.exercise_date: The RSUs became fully vested on June 10, 2026, the day prior to the 2026 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date. F3 · derivative.expiration_date: The RSUs became fully vested on June 10, 2026, the day prior to the 2026 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 16:49 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionCommon Stock | 14,083 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001252546-26-000003 · form4-06122026_080654.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,390 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. Read SEC document |
| June 12, 2025 Filed Jun 13, 2025 16:21 UTC | 908 Devices Inc. MASS · Entity 5564 | GrantStock Option (option to buy) · Derivative | 6,516 | $0.00 Strike: $7.19 | $0.00 |
DisclosureSEC source: 0001562180-25-004811 · primarydocument.xml · derivative · entry 5 HRUSOVSKY E KEVIN · CIK 0001252546 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,516 Underlying: Common Stock · 6,516 shares Expires 2035-06-11 F6 · derivative.exercise_date: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following June 12, 2025, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| June 12, 2025 Filed Jun 13, 2025 16:21 UTC | 908 Devices Inc. MASS · Entity 5564 | GrantRestricted Stock Units · Derivative | 14,083 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-004811 · primarydocument.xml · derivative · entry 4 HRUSOVSKY E KEVIN · CIK 0001252546 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,083 Underlying: Common Stock · 14,083 shares Expires not disclosed F4 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F5 · derivative.exercise_date: The RSUs become fully vested on June 12, 2026 or the day prior to the 2026 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. F5 · derivative.expiration_date: The RSUs become fully vested on June 12, 2026 or the day prior to the 2026 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 16:21 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionRestricted Stock Units · Derivative | 11,364 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-25-004811 · primarydocument.xml · derivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,364 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. F3 · derivative.exercise_date: The RSUs became fully vested on June 11, 2025, the day prior to the 2025 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date. F3 · derivative.expiration_date: The RSUs became fully vested on June 11, 2025, the day prior to the 2025 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date. Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 16:21 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionCommon Stock | 11,364 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-25-004811 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 151,307 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. Read SEC document |
| June 13, 2024 Filed Jun 14, 2024 16:21 UTC | 908 Devices Inc. MASS · Entity 5564 | GrantStock Option (option to buy) · Derivative | 15,996 | $0.00 Strike: $5.94 | $0.00 |
DisclosureSEC source: 0001562180-24-005064 · primarydocument.xml · derivative · entry 5 HRUSOVSKY E KEVIN · CIK 0001252546 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,996 Underlying: Common Stock · 15,996 shares Expires 2033-06-15 F6 · derivative.exercise_date: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following June 13, 2024, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| June 13, 2024 Filed Jun 14, 2024 16:21 UTC | 908 Devices Inc. MASS · Entity 5564 | GrantRestricted Stock Unit · Derivative | 11,364 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-005064 · primarydocument.xml · derivative · entry 4 HRUSOVSKY E KEVIN · CIK 0001252546 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,364 Underlying: Common Stock · 11,364 shares Expires not disclosed F4 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F5 · derivative.exercise_date: The RSUs become fully vested on June 13, 2025 or the day prior to the 2025 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. F5 · derivative.expiration_date: The RSUs become fully vested on June 13, 2025 or the day prior to the 2025 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 16:21 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionRestricted Stock Unit · Derivative | 7,777 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-24-005064 · primarydocument.xml · derivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,777 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. F3 · derivative.exercise_date: The RSUs became fully vested on June 12, 2024, the day prior to the 2024 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date. F3 · derivative.expiration_date: The RSUs became fully vested on June 12, 2024, the day prior to the 2024 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date. Read SEC document |
| June 12, 2024 Filed Jun 14, 2024 16:21 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionCommon Stock | 7,777 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-24-005064 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 139,943 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 17:51 UTC | 908 Devices Inc. MASS · Entity 5564 | GrantStock Option (option to buy) · Derivative | 12,076 | $0.00 Strike: $8.68 | $0.00 |
DisclosureSEC source: 0001562180-23-005306 · primarydocument.xml · derivative · entry 5 HRUSOVSKY E KEVIN · CIK 0001252546 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,076 Underlying: Common Stock · 12,076 shares Expires 2033-06-15 F6 · derivative.exercise_date: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following June 15, 2023, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 17:51 UTC | 908 Devices Inc. MASS · Entity 5564 | GrantRestricted Stock Units · Derivative | 7,777 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005306 · primarydocument.xml · derivative · entry 4 HRUSOVSKY E KEVIN · CIK 0001252546 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,777 Underlying: Common Stock · 7,777 shares Expires not disclosed F4 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F5 · derivative.exercise_date: The RSUs become fully vested on June 15, 2024 or the day prior to the 2024 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. F5 · derivative.expiration_date: The RSUs become fully vested on June 15, 2024 or the day prior to the 2024 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 17:51 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionRestricted Stock Units · Derivative | 4,771 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-005306 · primarydocument.xml · derivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,771 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. F3 · derivative.exercise_date: The RSUs became fully vested on June 14, 2023, the day prior to the 2023 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date. F3 · derivative.expiration_date: The RSUs became fully vested on June 14, 2023, the day prior to the 2023 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 17:51 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionCommon Stock | 4,771 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-23-005306 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,166 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. This transaction represents the settlement of RSUs in shares of Common Stock on their scheduled vesting date. Read SEC document |
| December 19, 2022 Filed Feb 14, 2023 19:30 UTC | 908 Devices Inc. MASS · Entity 5564 | GiftCommon Stock | 193,176 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001395 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 329,675 F1 · kind: On December 19, 2022, 193,176 shares of the Issuer's Common Stock were transferred from the reporting person to the E. Kevin Hrusovsky 2012 Irrevocable Trust. This was a bona fide gift with no payment in consideration. F1 · price: On December 19, 2022, 193,176 shares of the Issuer's Common Stock were transferred from the reporting person to the E. Kevin Hrusovsky 2012 Irrevocable Trust. This was a bona fide gift with no payment in consideration. F2 · ownership.nature: The securities are owned directly by the E. Kevin Hrusovsky 2012 Irrevocable Trust. The reporting person's spouse and children are trustees of E. Kevin Hrusovsky 2012 Irrevocable Trust and have joint voting and dispositive control with respect to all securities held by E. Kevin Hrusovsky 2012 Irrevocable Trust and the reporting person may be deemed to be the beneficial owner of the securities held by E. Kevin Hrusovsky 2012 Irrevocable Trust. Read SEC document |
| December 19, 2022 Filed Feb 14, 2023 19:30 UTC | 908 Devices Inc. MASS · Entity 5564 | GiftCommon Stock | 193,176 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-23-001395 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,395 F1 · kind: On December 19, 2022, 193,176 shares of the Issuer's Common Stock were transferred from the reporting person to the E. Kevin Hrusovsky 2012 Irrevocable Trust. This was a bona fide gift with no payment in consideration. F1 · price: On December 19, 2022, 193,176 shares of the Issuer's Common Stock were transferred from the reporting person to the E. Kevin Hrusovsky 2012 Irrevocable Trust. This was a bona fide gift with no payment in consideration. Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 16:06 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionStock Option (option to buy) · Derivative | 76,016 | $0.00 Strike: $0.35 | $0.00 |
DisclosureSEC source: 0001562180-22-007809 · primarydocument.xml · derivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.001 · 76,016 shares Expires 2023-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares underlying the option are fully vested and immediately exercisable. Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 16:06 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionCommon Stock, par value $0.001 | 76,016 | $0.35 | $26,605.60 |
DisclosureSEC source: 0001562180-22-007809 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 05, 2022 Filed Jul 6, 2022 16:07 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 960 | $16.57 | $15,906.14 |
DisclosureSEC source: 0001562180-22-005564 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 910,249 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 2,068 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $16.18 to $17.10. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 58,604 restricted stock units and 39,815 shares of common stock subject to performance based vesting. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 16:18 UTC | 908 Devices Inc. MASS · Entity 5564 | GrantStock Option (option to buy) · Derivative | 7,970 | $0.00 Strike: $14.15 | $0.00 |
DisclosureSEC source: 0001562180-22-005197 · primarydocument.xml · derivative · entry 5 HRUSOVSKY E KEVIN · CIK 0001252546 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,970 Underlying: Common Stock, par value $0.001 · 7,970 shares Expires 2032-06-16 F5 · derivative.exercise_date: The shares underlying the option become vested and exercisable in substantially equal monthly installments over the 12 months following June 16, 2022, subject to the reporting person's continued service through the applicable vesting date. Read SEC document |
| June 16, 2022 Filed Jun 17, 2022 16:18 UTC | 908 Devices Inc. MASS · Entity 5564 | GrantRestricted Stock Unit · Derivative | 4,771 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-005197 · primarydocument.xml · derivative · entry 4 HRUSOVSKY E KEVIN · CIK 0001252546 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,771 Underlying: Common Stock, par value $0.001 · 4,771 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F4 · derivative.exercise_date: The RSUs become fully vested on June 16, 2023 or the day prior to the 2023 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. F4 · derivative.expiration_date: The RSUs become fully vested on June 16, 2023 or the day prior to the 2023 Annual Meeting of the Stockholders of 908 Devices Inc., whichever occurs first, subject to the reporting person's continued service through the applicable vesting date, provided that, if the reporting person terminates their service for any reason, then a prorated number of RSUs will vest. The RSUs have no expiration date. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 16:18 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionRestricted Stock Unit · Derivative | 1,379 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-005197 · primarydocument.xml · derivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, par value $0.001 · 1,379 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. F3 · derivative.exercise_date: The RSUs became fully vested on June 15, 2022, the day prior to the 2022 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date. F3 · derivative.expiration_date: The RSUs became fully vested on June 15, 2022, the day prior to the 2022 Annual Meeting of the Stockholders of 908 Devices Inc. The RSUs have no expiration date. Read SEC document |
| June 15, 2022 Filed Jun 17, 2022 16:18 UTC | 908 Devices Inc. MASS · Entity 5564 | Exercise / conversionCommon Stock, par value $0.001 | 1,379 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001562180-22-005197 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,555 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.001, when vested. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 16:19 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 712 | $17.47 | $12,441.20 |
DisclosureSEC source: 0001562180-22-004770 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 911,209 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 2,068 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $17.35 to 17.53. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 60,672 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| May 02, 2022 Filed May 3, 2022 16:34 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 127 | $22.68 | $2,880.58 |
DisclosureSEC source: 0001562180-22-003674 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 911,921 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 2,068 RSUs. F4 · price: This transaction was executed in multiple trades at prices ranging from $22.67 to $22.705. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 62,740 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| May 02, 2022 Filed May 3, 2022 16:34 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 522 | $22.29 | $11,634.23 |
DisclosureSEC source: 0001562180-22-003674 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 912,048 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 2,068 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $21.67 to $22.65. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 62,740 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| April 25, 2022 Filed Apr 27, 2022 16:02 UTC | Quanterix Corp QTRX · Entity 6649 | GrantStock Options (Right to buy) · Derivative | 59,718 | $0.00 Strike: $24.40 | $0.00 |
DisclosureSEC source: 0001562180-22-003552 · primarydocument.xml · derivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,718 Underlying: Common Stock · 59,718 shares Expires 2032-04-25 F3 · derivative.exercise_date: The option vests as to 25% of the shares on April 25, 2023, and the remaining 75% vests in 36 equal monthly installments at the end of each month beginning on April 30, 2023. Read SEC document |
| April 25, 2022 Filed Apr 27, 2022 16:02 UTC | Quanterix Corp QTRX · Entity 6649 | GrantCommon Stock | 25,594 | $0.00 | $0.00 |
DisclosureSEC source: 0001562180-22-003552 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 912,570 F1 · shares: Represents shares of stock issuable upon vesting of restricted stock units (RSUs). The RSUs vest as to 25% of the shares on April 25, 2023, with the remaining 75% vesting in 36 equal monthly installments at the end of each month thereafter beginning on April 30, 2023. F2 · balance_after: Includes 64,808 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 16:03 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 868 | $29.79 | $25,860.24 |
DisclosureSEC source: 0001562180-22-003219 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 886,976 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 2,068 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $29.25 to $30.00. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 39,214 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 17:01 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 158 | $32.15 | $5,079.70 |
DisclosureSEC source: 0001562180-22-002275 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 887,844 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 2,068 RSUs. F3 · balance_after: Includes 41,282 restricted stock units. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 17:01 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 431 | $31.21 | $13,450.04 |
DisclosureSEC source: 0001562180-22-002275 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 888,002 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 2,068 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $30.84 to $31.83. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 41,282 restricted stock units. Read SEC document |
| February 09, 2022 Filed Feb 9, 2022 17:10 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,364 | $34.97 | $47,697.17 |
DisclosureSEC source: 0001562180-22-001270 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 888,433 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 4,599 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $34.9435 to $34.985. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 43,350 restricted stock units. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 16:00 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 158 | $32.15 | $5,079.70 |
DisclosureSEC source: 0001562180-22-001135 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 889,797 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 1,685 RSUs. F3 · balance_after: Includes 47,949 restricted stock units. Read SEC document |
| February 02, 2022 Filed Feb 4, 2022 16:00 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 431 | $31.21 | $13,450.04 |
DisclosureSEC source: 0001562180-22-001135 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 889,955 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 1,685 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $30.84 to $31.83. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 47,949 restricted stock units. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 16:06 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 3,715 | $41.91 | $155,683.02 |
DisclosureSEC source: 0001562180-22-000229 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 890,386 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,935 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $41.71 to $42.16. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 49,634 restricted stock units. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 16:20 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 131 | $41.00 | $5,371.00 |
DisclosureSEC source: 0001562180-21-007443 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 894,101 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,935 RSUs. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 16:20 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 3,579 | $40.26 | $144,105.93 |
DisclosureSEC source: 0001562180-21-007443 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 894,232 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,935 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $40.00 to $40.92. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 57,569 restricted stock units. Read SEC document |
| November 10, 2021 Filed Nov 10, 2021 16:06 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 400 | $55.97 | $22,387.00 |
DisclosureSEC source: 0001562180-21-006965 · primarydocument.xml · nonDerivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 897,811 F1 · shares: The sale of shares was effected pursuant to a 10b5-1 trading plan adopted on December 14, 2020. F5 · price: This transaction was executed in multiple trades at prices ranging from $55.93 to $56.015. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 65,504 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| November 10, 2021 Filed Nov 10, 2021 16:06 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 3,700 | $55.37 | $204,861.97 |
DisclosureSEC source: 0001562180-21-006965 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 898,211 F1 · shares: The sale of shares was effected pursuant to a 10b5-1 trading plan adopted on December 14, 2020. F4 · price: This transaction was executed in multiple trades at prices ranging from $54.76 to $55.755. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 65,504 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| November 10, 2021 Filed Nov 10, 2021 16:06 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 900 | $54.05 | $48,648.51 |
DisclosureSEC source: 0001562180-21-006965 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 901,911 F1 · shares: The sale of shares was effected pursuant to a 10b5-1 trading plan adopted on December 14, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $53.73 to $54.44. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 65,504 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 16:19 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 979 | $53.14 | $52,028.86 |
DisclosureSEC source: 0001562180-21-006834 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 902,811 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,935 RSUs. F4 · price: This transaction was executed in multiple trades at prices ranging from $52.96 to $53.78.The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 65,504 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 16:19 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 2,526 | $52.40 | $132,355.83 |
DisclosureSEC source: 0001562180-21-006834 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 903,790 F1 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,935 RSUs. F2 · price: This transaction was executed in multiple trades at prices ranging from $51.86 to $52.85. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 65,504 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| October 22, 2021 Filed Oct 22, 2021 17:48 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 100 | $51.63 | $5,163.00 |
DisclosureSEC source: 0001562180-21-006622 · primarydocument.xml · nonDerivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 906,316 F1 · shares: The sale of shares was effected pursuant to a 10b5-1 trading plan adopted on December 14, 2020. F3 · balance_after: Includes 73,439 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| October 22, 2021 Filed Oct 22, 2021 17:48 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 3,000 | $51.00 | $152,997.60 |
DisclosureSEC source: 0001562180-21-006622 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 906,416 F1 · shares: The sale of shares was effected pursuant to a 10b5-1 trading plan adopted on December 14, 2020. F4 · price: This transaction was executed in multiple trades at prices ranging from $50.63 to $51.50. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 73,439 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| October 22, 2021 Filed Oct 22, 2021 17:48 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 1,900 | $50.19 | $95,359.29 |
DisclosureSEC source: 0001562180-21-006622 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 909,416 F1 · shares: The sale of shares was effected pursuant to a 10b5-1 trading plan adopted on December 14, 2020. F2 · price: This transaction was executed in multiple trades at prices ranging from $49.56 to $50.54. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F3 · balance_after: Includes 73,439 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| October 01, 2021 Filed Oct 4, 2021 16:02 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 3,594 | $51.20 | $184,014.96 |
DisclosureSEC source: 0001562180-21-006230 · primarydocument.xml · nonDerivative · entry 3 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 911,316 F4 · shares: The sales of shares reported on this Form 4 were made solely to cover tax obligations upon the vesting of 7,935 RSUs. F5 · balance_after: Includes 73,439 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 16:02 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 4,600 | $49.22 | $226,432.70 |
DisclosureSEC source: 0001562180-21-006230 · primarydocument.xml · nonDerivative · entry 2 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 914,910 F1 · shares: The sale of shares was effected pursuant to a 10b5-1 trading plan adopted on December 14, 2020. F3 · price: This transaction was executed in multiple trades at prices ranging from $48.74 to $49.59. The price reported reflects the weighted average sale price. The reporting person undertakes to provide upon request to the SEC staff, the issuer or any security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. F2 · balance_after: Includes 81,374 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
| September 30, 2021 Filed Oct 4, 2021 16:02 UTC | Quanterix Corp QTRX · Entity 6649 | SaleCommon Stock | 400 | $47.54 | $19,016.00 |
DisclosureSEC source: 0001562180-21-006230 · primarydocument.xml · nonDerivative · entry 1 HRUSOVSKY E KEVIN · CIK 0001252546 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 919,510 F1 · shares: The sale of shares was effected pursuant to a 10b5-1 trading plan adopted on December 14, 2020. F2 · balance_after: Includes 81,374 restricted stock units and 39,815 shares of common stock that are subject to performance based vesting. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.